Generation of UL128-shRNA transduced fibroblasts for the release of cell-free virus from clinical human cytomegalovirus isolates
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Generation of UL128-shRNA transduced fibroblasts for the release of cell-free virus from clinical human cytomegalovirus isolates
Authors
Keywords
-
Journal
BIOTECHNIQUES
Volume -, Issue -, Pages -
Publisher
Future Science Ltd
Online
2023-10-17
DOI
10.2144/btn-2023-0046
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combined knockdown of RL13 and UL128 for release of cell-free infectivity from recent HCMV isolates
- (2022) Nina Weiler et al. JOURNAL OF VIROLOGICAL METHODS
- Role of Envelope Glycoprotein Complexes in Cell-Associated Spread of Human Cytomegalovirus
- (2021) Nina Weiler et al. Viruses-Basel
- Pathogenesis of human cytomegalovirus in the immunocompromised host
- (2021) Paul Griffiths et al. NATURE REVIEWS MICROBIOLOGY
- Advances in the genotypic diagnosis of cytomegalovirus antiviral drug resistance
- (2020) Sunwen Chou ANTIVIRAL RESEARCH
- Specialization for cell-free or cell-to-cell spread of BAC-cloned HCMV strains is determined by factors beyond the UL128-131 and RL13 loci.
- (2020) Eric P. Schultz et al. JOURNAL OF VIROLOGY
- Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta-analysis
- (2019) Mohamed Zuhair et al. REVIEWS IN MEDICAL VIROLOGY
- The N-terminus of the human cytomegalovirus glycoprotein O is important for binding to the cellular receptor PDGFRα
- (2019) Cora Stegmann et al. JOURNAL OF VIROLOGY
- Fast breakthrough of resistant cytomegalovirus during secondary letermovir prophylaxis in a hematopoietic stem cell transplant recipient
- (2019) Susanne Jung et al. BMC INFECTIOUS DISEASES
- Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7)
- (2019) Per Ljungman et al. LANCET INFECTIOUS DISEASES
- Human Cytomegalovirus Genomes Sequenced Directly From Clinical Material: Variation, Multiple-Strain Infection, Recombination, and Gene Loss
- (2019) Nicolás M Suárez et al. JOURNAL OF INFECTIOUS DISEASES
- Safety considerations with current and emerging antiviral therapies for cytomegalovirus infection in transplantation
- (2019) Guy El Helou et al. Expert Opinion On Drug Safety
- Letermovir Resistance Analysis in a Clinical Trial of Cytomegalovirus Prophylaxis for Hematopoietic Stem Cell Transplant Recipients
- (2019) Cameron M Douglas et al. JOURNAL OF INFECTIOUS DISEASES
- Molecular Determinants and the Regulation of Human Cytomegalovirus Latency and Reactivation
- (2018) Donna Collins-McMillen et al. Viruses-Basel
- Biological relevance of Cytomegalovirus genetic variability in congenitally and postnatally infected children
- (2018) Ganna Galitska et al. JOURNAL OF CLINICAL VIROLOGY
- Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
- (2017) Francisco M. Marty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Approved Antiviral Drugs over the Past 50 Years
- (2016) Erik De Clercq et al. CLINICAL MICROBIOLOGY REVIEWS
- Impact of Sequence Variation in the UL128 Locus on Production of Human Cytomegalovirus in Fibroblast and Epithelial Cells
- (2013) I. Murrell et al. JOURNAL OF VIROLOGY
- Human cytomegalovirus RL13 gene transcripts in a clinical strain
- (2011) Mali Li et al. VIRUS GENES
- Reconstruction of the complete human cytomegalovirus genome in a BAC reveals RL13 to be a potent inhibitor of replication
- (2010) Richard J. Stanton et al. JOURNAL OF CLINICAL INVESTIGATION
- Sequential mutations associated with adaptation of human cytomegalovirus to growth in cell culture
- (2010) D. J. Dargan et al. JOURNAL OF GENERAL VIROLOGY
- Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection
- (2010) Michael J. Cannon et al. REVIEWS IN MEDICAL VIROLOGY
- How we treat cytomegalovirus in hematopoietic cell transplant recipients
- (2009) M. Boeckh et al. BLOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now